<prompt> Daclizumab acts through ?cGMP activationAdenylcyclase inhibitionIL 2 receptor blockerIL10 receptor blocker  <response>: Ans. is c i.e., IL 2 receptor blocker Monoclonal antibodies daclizumab and basiliximab that block the interleukin 2 receptor and are used in prevention of graft rejection as immunosuppresant. 